about
Plant extracts inhibit ADP-induced platelet activation in humans: their potential therapeutic role as ADP antagonistsPharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersPeptidomimetic thrombin inhibitors.Current concepts for the prevention of venous thromboembolism.Investigation into the effects of antioxidant-rich extract of Tamarindus indica leaf on antioxidant enzyme activities, oxidative stress and gene expression profiles in HepG2 cellsBio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.Antiplatelet agents in clinical practice and their haemorrhagic risk.Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice.Attenuation of the P2Y receptor-mediated control of neuronal Ca2+ channels in PC12 cells by antithrombotic drugs.Peptide Mimetic Drugs for Modulating Thrombosis and Hemostasis.Cytoprotective effects of essential oil of Pinus halepensis L. against aspirin-induced toxicity in IEC-6 cells.Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.In vitro shear stress-induced platelet activation: sensitivity of human and bovine blood.Antithrombotic properties of Ixolaris, a potent inhibitor of the extrinsic pathway of the coagulation cascade.Polyphenol fatty acid esters as serine protease inhibitors: a quantum-chemical QSAR analysisTherapeutic applications of serine protease inhibitors
P2860
Q26861282-5073566A-36ED-49BF-BC33-162A3B24BA23Q28200449-6AC907CB-4A7E-4E96-A183-4D41EAC9BA58Q34650267-E6C959B2-18FE-44C3-9BBF-DC4630E1EA63Q36034723-256D88E8-5A2E-46DE-9EA1-7A4E1CE3C693Q36257914-F5822855-DF2E-42AD-B9F3-985A7B9CD235Q36778167-A0579500-4822-4BEE-AB28-E13EF9633707Q37059195-038F2F3A-E0B6-407E-8F6F-3E445F6E1B18Q40600288-56FCB9A1-0C8C-4364-9DE7-5FF0B76A7F69Q43263545-84292BF0-2CFD-4929-886D-211BDD5635C8Q44874794-EE7E287C-B206-4F6C-BFAA-97AFC8528F41Q46334396-5A4EB35D-3B73-4ED9-98F2-DD728742E5A1Q50549344-ACC7416D-78D5-4882-A02F-E13101B08754Q50935485-57644C10-D001-4F13-8B23-0FBCFFF6B171Q55098431-FB4229B1-F47B-4592-A134-55A5A8316A0EQ56927532-710545D9-09A5-458D-8F6D-B48106F14612Q58863311-3028CE76-F02E-4B10-BDB9-49039D903871
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Novel approaches to the treatment of thrombosis.
@ast
Novel approaches to the treatment of thrombosis.
@en
Novel approaches to the treatment of thrombosis.
@nl
type
label
Novel approaches to the treatment of thrombosis.
@ast
Novel approaches to the treatment of thrombosis.
@en
Novel approaches to the treatment of thrombosis.
@nl
prefLabel
Novel approaches to the treatment of thrombosis.
@ast
Novel approaches to the treatment of thrombosis.
@en
Novel approaches to the treatment of thrombosis.
@nl
P1476
Novel approaches to the treatment of thrombosis.
@en
P2093
Giancarlo Agnelli
Paolo Gresele
P356
10.1016/S0165-6147(00)01885-X
P577
2002-01-01T00:00:00Z